|
1
|
Luo J, Adami HO, Reilly M, Ekbom A,
Nordenvall C and Ye W: Interpreting trends of pancreatic cancer
incidence and mortality: a nation-wide study in Sweden (1960–2003).
Cancer Causes Control. 19:89–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beger HG, Rau B, Gansauge F, Leder G,
Schwarz M and Poch B: Pancreatic cancer - low survival rates. Dtsch
Arztebl Int. 105:255–262. 2008.PubMed/NCBI
|
|
3
|
Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W,
Yu G and Gao Y: The prognostic potential and oncogenic effects of
PRR11 expression in hilar cholangiocarcinoma. Oncotarget.
6:20419–20433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji Y, Xie M, Lan H, Zhang Y, Long Y, Weng
H, Li D, Cai W, Zhu H, Niu Y, et al: PRR11 is a novel gene
implicated in cell cycle progression and lung cancer. Int J Biochem
Cell Biol. 45:645–656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song Z, Liu W, Xiao Y, Zhang M, Luo Y,
Yuan W, Xu Y, Yu G and Hu Y: PRR11 is a prognostic marker and
potential oncogene in patients with gastric cancer. PLoS One.
10:e01289432015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Zhang Y, Zhang C, Weng H, Li Y,
Cai W, Xie M, Long Y, Ai Q, Liu Z, et al: The gene pair PRR11 and
SKA2 shares a NF-Y-regulated bidirectional promoter and contributes
to lung cancer development. Biochim Biophys Acta. 1849:1133–1144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang C, Zhang Y, Li Y, Zhu H, Wang Y, Cai
W, Zhu J, Ozaki T and Bu Y: PRR11 regulates late-S to G2/M phase
progression and induces premature chromatin condensation (PCC).
Biochem Biophys Res Commun. 458:501–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saif MW: Research in pancreatic cancer: an
update after ASCO 2012. JOP. 13:330–331. 2012.PubMed/NCBI
|
|
9
|
Maisonneuve P and Lowenfels AB:
Epidemiology of pancreatic cancer: an update. Dig Dis. 28:645–656.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grønborg M, Kristiansen TZ, Iwahori A,
Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins
MG, et al: Biomarker discovery from pancreatic cancer secretome
using a differential proteomic approach. Mol Cell Proteomics.
5:157–171. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stevens L, Pathak S, Nunes QM,
Pandanaboyana S, Macutkiewicz C, Smart N and Smith AM: Prognostic
significance of pre-operative C-reactive protein and the
neutrophil-lymphocyte ratio in resectable pancreatic cancer: a
systematic review. HPB Oxf. 17:285–291. 2015. View Article : Google Scholar
|
|
12
|
Kou T, Kanai M, Yamamoto M, Xue P, Mori Y,
Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, et al: Prognostic model
for survival based on readily available pretreatment factors in
patients with advanced pancreatic cancer receiving palliative
chemotherapy. Int J Clin Oncol. 21:118–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Earl J, Garcia-Nieto S, Martinez-Avila JC,
Montans J, Sanjuanbenito A, Rodríguez-Garrote M, Lisa E, Mendía E,
Lobo E, Malats N, et al: Circulating tumor cells (Ctc) and kras
mutant circulating free DNA (cfDNA) detection in peripheral blood
as biomarkers in patients diagnosed with exocrine pancreatic
cancer. BMC Cancer. 15:7972015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kishikawa T, Otsuka M, Ohno M, Yoshikawa
T, Takata A and Koike K: Circulating RNAs as new biomarkers for
detecting pancreatic cancer. World J Gastroenterol. 21:8527–8540.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Xiang J, Chen R, Fu D, Hong D, Hao
J, Li Y, Li J, Li S, Mou Y, et al: Chinese Study Group for
Pancreatic Cancer (CSPAC): The clinical utility of CA125/MUC16 in
pancreatic cancer: a consensus of diagnostic, prognostic and
predictive updates by the Chinese Study Group for Pancreatic Cancer
(CSPAC). Int J Oncol. 48:900–907. 2016.PubMed/NCBI
|
|
16
|
Zhou F, Liu H, Zhang X, Shen Y, Zheng D,
Zhang A, Lai Y and Li H: Proline-rich protein 11 regulates
epithelial-to-mesenchymal transition to promote breast cancer cell
invasion. Int J Clin Exp Pathol. 7:8692–8699. 2014.PubMed/NCBI
|
|
17
|
Ho HY, Rohatgi R, Ma L and Kirschner MW:
CR16 forms a complex with N-WASP in brain and is a novel member of
a conserved proline-rich actin-binding protein family. Proc Natl
Acad Sci USA. 98:11306–11311. 2001. View Article : Google Scholar : PubMed/NCBI
|
